ABOUT USOrganization & History

Offices

Tokyo Tokyo Branch Office 3rd Floor Surugadai Building, 1-2-5 Kandasurugadai, Chiyoda-Ku, Tokyo 101-0062, Japan

International Business Unit
Tel: +81-3-5282-2485
Asia Business Unit
Tel: +81-3-5282-2478
Koriyama Head Office 1-1 Tairanoue, Sasagawa, Asaka-machi, Koriyama,
Fukushima 963-0196, Japan
Beijing Beijing Representative Office 807, Building B, Lucky Tower, No.3 North Dongsanhuan Road, Chaoyang District, Beijing, China

Asia Business Unit
Tel: +86-010-64604489

Company Outline

本社

Corporate Name Nippon Zenyaku Kogyo Co., Ltd.
Date of Establishment May 1946
Capital 170 million yen
Company
Representatives
Kuniaki Fukui, Chairman
Toshikazu Fukui, President
Core Business Development, manufacturing, import, export and sales of veterinary pharmaceuticals, biologics and medical devices.
Number of Employees 660 (794 including employees of group companies)
Sales 34.1 billion yen (FY 2017)
Main Customers Livestock farms and related groups, large and small animal clinics
Main Financing Banks The Toho Bank, Ltd., Mizuho Bank, Ltd., The Bank of Tokyo-Mitsubishi UFJ, Ltd. The Norinchukin Bank
Manufacturing Sites Koriyama, Fukushima Prefecture, Japan
Kobayashi, Miyazaki Prefecture, Japan
Tianjin, China
Subsidiaries Nippon Biologicals Inc.
Vetoquinol-Zenoaq K.K.
ZENOAQ RESOURCE CO., LTD.

Organizational Chart

Organizational Chart

May 2018
Appointment of Mr. Toshikazu Fukui as President.
December 2017 Winner of the Fukushima Industry Award 2017.
November 2017 Completion of the construction of the new quality control center in Koriyama (Asaka), Japan.
November 2016 Winner of the Japan Quality Award 2016.
May 2016
Celebration of the 70th year anniversary of ZENOAQ.
Celebration of the 70th year anniversary of ZENOAQ.
January 2016
Establishment of Vetoquinol-Zenoaq K.K., a joint venture with Vetoquinol SA.
Establishment of Vetoquinol-Zenoaq K.K., a joint venture with Vetoquinol SA.
July 2015 Research and development collaboration with Nexvet.
January 2015 Winner of the Animal Pharm Award 2014 for Best Company in Asia/ Australasia.
July 2014 Completion of the construction of the state-of-the-art biological manufacturing plant (Third Manufacturing Plant) in Koriyama (Asaka), Japan.
July 2013 Completion of the construction of the new main administration building in Koriyama (Asaka), Japan.
July 2011
Establishment of the Tokyo Branch Office.
bill
March 2011 ZENOAQ's head office severely affected by the Great East Japan Earthquake.
Beginning of road to recovery.
April 2009 Business grouping with Nippon Biologicals Inc., a company that develops and imports avian vaccines.
April 2009
Appointment of Mr. Kuniaki Fukui, former President of Nippon Zenyaku Kogyo Co., Ltd, as Chairman.
Appointment of Mr. Keiichi Takano to Mr. Fukui’s previous role as President.
Appointment of Mr. Keiichi Takano to Mr. Fukui’s previous role as President.
April, May, December 2008 Completion of the construction of new buildings of the Central Research Laboratory Animal Research Center in Koriyama (Asaka), Japan.
December 2007 Business tie-up with IDEXX Laboratories K.K..
January 2005
Establishment of the Beijing Representatine Office in China.
Establishment of the Beijing Representatine Office in China.
February 2004 Business tie-up with Nippon Biologicals, Inc..
March 2003 Business tie-up with Zinpro Animal Nutrition Japan K.K..
June 2002 Commencement of import and sales of mineral salt blocks that are made in China.
August 2001 Announcement of the corporate brand, ZENOAQ.
April 2001 Integration of the head office and 6 marketing subsidiaries throughout Japan as Nippon Zenyaku Kogyo Co., Ltd.
Set up of sales system according to animal groups (Dairy Cattle, Beef Cattle, Swine, Avian and Companion Animal).
February 2001
Set up of Tianjin Zenyaku Animal Health Co., Ltd. as a manufacturing plant in China.
manufacturing plant
January 2001 Merging of Merial Nippon Zenyaku Limited with Merial Japan Limited.
Nippon Zenyaku Kogyo undertakes a portion of the equity.
January 1999 Creation of the Avian Business Division.
May 1996 Celebration of the 50th year anniversary of Nippon Zenyaku Kogyo.
April 1996
Establishment of Rhone-Merieux Nippon Zenyaku Limited, a joint venture with Rhone Merieux (later changed to Merial Nippon Zenyaku Limited).
Establishment of Rhone-Merieux Nippon Zenyaku Limited
October 1989 Establishment of the Clinical Research Farm in Ono, Japan.
May 1988 Appointment of Mr. Kuniaki Fukui as President.
November 1983 Establishment of Kobayashi manufacturing plant.
June 1982 Establishment of the Central Research Laboratory.
April 1976 Business tie-up with Fujisawa Pharmaceutical Co., Ltd..
March 1975
Completion of the construction of the new manufacturing plant in Koriyama (Asaka), Japan.
Establishment of Rhone-Merieux Nippon Zenyaku Limited
August 1972 Business tie-up with SmithKline and French Laboratories (SK&F).
April 1971 Establishment of the Kushiro manufacturing plant.
March 1962 Commencement of manufacturing of vial products.
January 1958
Establishment of a manufacturing plant for mineral salt blocks.
Establishment of a manufacturing plant
December 1956 Establishment of an additional plant in Koriyama (Showa), Japan.
September 1955 Commencement of manufacturing of antibiotic formulations.
April 1953 Successful R&D of Neo Hexaron, a liver fluke parasiticide in Sadogashima.
May 1949 Company name changed to Nippon Zenyaku Kogyo Co., Ltd.
April 1948
Commencement of the manufacturing veterinary pharmaceuticals, such as OSM and OSM Strong.
OSM and OSM
May 1946
Establishment of Asahi Yakuhin Kogyo Co., Ltd with a capital of 180,000 yen.
Commencement of manufacturing in Koriyama (Miyata), Japan.
Establishment of Asahi Yakuhin Kogyo Co., Ltd